title: [Breast MR imaging: validated indications and unsolved problems].
abstract: The contribution of breast MR imaging for second intention after a complete assessment (mammography, ultra-sound, and possibly histological) of breast pathology is not any more to show. Its limits are due primarily to its great sensitivity responsible for false positive (20 to 40 %) and to the difficulty in carrying out biopsies under guidance IRM of the lesions not found in second intention by the mammography and ultrasound (50 to 75 %). Its use reasoned by respecting the indications recognized as useful and validated for the clinical plan is an imperative condition to avoid noxious assumptions of responsibility of the patients.
authors.affiliation: Département d'imagerie, Centre Oscar-Lambret, 3, rue Frédéric-Combemale, 59000 Lille, France. s-taieb@o-lambret.fr
authors.forename: Sophie
authors.initials: S
authors.lastname: Taïeb
authors.forename: Luc
authors.initials: L
authors.lastname: Ceugnart
mesh_terms: D001940:Breast / Q000473:pathology*; D001941:Breast Diseases / Q000473:pathology; D001943:Breast Neoplasms / Q000473:pathology*; D002114:Calcinosis / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000592:standards*; D012680:Sensitivity and Specificity